Area of Interest Immuno-Oncology Immuno-Oncology with Mass Cytometry

Immuno-Oncology With Mass Cytometry

Emerging Approaches to Improving Adoptive Cell Therapy

Flow cytometry with CyTOF® is enabling improved profiling of CAR (chimeric antigen receptor) cell products and their functional characteristics.

The use of CAR cells as therapeutic agents in cancer is expanding at a rapid pace, but significant challenges remain. Investigators are taking innovative approaches to address these challenges.

The expert research shared here spans diverse aspects of CAR cell therapeutic development, from expanding our understanding of immune cell function to improving CAR T manufacturing to monitoring CAR cells in clinical research trials.

» Contact us for more info.

» Learn more about immune profiling with CyTOF.

Publications Trending Now

A compilation of research studies using CyTOF technology to enhance safety and efficacy of CAR T cell therapy


Using CyTOF for CAR T analysis

Luke Stewart

A streamlined research assay for longitudinal Immune monitoring of cellular therapies





Molecular Characterization of CAR T Cells Using Mass Cytometry

Ilaria Michelozzi
Postdoctoral Researcher, University College London

Ilaria Michelozzi

Expanding CAR T Cell Profiling to Accelerate Therapeutic Insights

Greg Hopkins
Associate Manager, Scientist, 2seventy bio™

Greg Hopkins

Understanding the Metabolic Dynamics of T Cells and CAR T Cells From Single-Cell Data

Matthew Spitzer, PhD
Assistant Professor, University of California San Francisco (UCSF)

Matthew Spitzer

Introducing CyTOF XT™ and Maxpar® Direct™ Assays for Efficient High-Content Immune Profiling

Emily Thrash, PhD
Field Application Specialist, Proteomics, Standard BioTools™

Emily Thrash

Mass Cytometry: A Robust Platform for the Comprehensive Immunomonitoring of CAR T Cell Therapies

Jonathan Caron, PhD
Researcher, Assistance Publique – Hôpitaux de Paris

Jonathan Caron

Interrogating CAR T Cell Spatiotemporal Plasticity 

Lior Goldberg, MD
Pediatric Oncologist, Physician-Scientist, City of Hope Comprehensive Cancer

Lior Goldberg

Customer Stories

Learn more about how our customers are leveraging Standard BioTools technology


Kara Davis, DO

Medium sized color headshot image of Kara Davis, DO

Predicting relapse in childhood leukemia and expanding therapy options

Evan Newell, PhD


Evan Newell on decoding immune cell heterogeneity with mass cytometry

Wendy Fantl, PhD

Spotlight MC Fantl Wendy

On the right path to better ovarian cancer diagnosis and treatment

background pattern

No CyTOF? No problem!

We can help you convert your fluorescence panel and find a service provider.

Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.